20118239_1|20118239|17119|#section_info|0:0|Initially, MBLs were tested for their abilities to bind to MASP-2A, using surface plasmon resonance. As expected, wild-type bound with complex kinetics compatible with the formation of 1:1 complexes, together with binding of a second MASP at relatively high protein concentrations (19).|#main_body|GO:0005515|protein binding|#go_definition|IPI|GOA|Mbl1(24548)|#gene_synonym
0.67	20118239_78|20118239|10031|EXPERIMENTAL PROCEDURES|0:0|Wild-type SP-A and all mutants bound to the affinity matrix, confirming that they were folded correctly.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20118239_170|20118239|25777|RESULTS|0:0|As expected, wild-type SP-A, which does not bind to the MASP at all, and SPA-KL, which binds only weakly, did not activate the MASP (Fig. 6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20118239_205|20118239|29998|DISCUSSION|0:0|However, in an alternative but equally valid possibility, binding of the zymogen MASP to MBL (or ficolin) induces strain into circulating complexes, which releases upon pathogen binding to trigger activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20118239_53|20118239|6889|Introduction|0:0|As yet, the only established difference between these proteins and their structural analogues is their ability to bind to MASPs or C1rs tetramers.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20118239_118|20118239|16382|RESULTS|0:0|B, binding of MASP-2A to immobilized MBLs by surface plasmon resonance.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20118239_200|20118239|28989|DISCUSSION|0:0|Thus, much of the binding specificity is probably mediated through the architectures of the subcomponents and the multivalent nature of the interactions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20118239_89|20118239|11544|EXPERIMENTAL PROCEDURES|0:0|MBL was immobilized on the chip surface rather than used as a soluble ligand because it bound to the chip, thereby masking analysis of the protein-protein interactions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20118239_101|20118239|13988|RESULTS|0:0|Consequently, during complex formation, the binding sites on the MBL stalks must either face inward or reorient so that the correct collagen-CUB domain interactions are formed.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_159|20118239|24607|RESULTS|0:0|Binding of MASP-2A to immobilized SP-As by surface plasmon resonance.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_193|20118239|27501|DISCUSSION|0:0|The presence of any additional binding sites for MASP on MBL can be completely ruled out from the data presented here.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_197|20118239|28989|DISCUSSION|0:0|Thus, the less stringent binding requirements of MASP-2 are relatively unusual.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_207|20118239|29998|DISCUSSION|0:0|In the work described here, MASP binding leads to constitutive activation by SP-A, even in the absence of a target.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20118239_2|20118239|17119|#section_info|0:0|Initially, MBLs were tested for their abilities to bind to MASP-2A, using surface plasmon resonance. As expected, wild-type bound with complex kinetics compatible with the formation of 1:1 complexes, together with binding of a second MASP at relatively high protein concentrations (19).|#main_body|GO:0005515|protein binding|#go_definition|IPI|GOA|Masp2(64459)|#gene_synonym
0.67	20118239_78|20118239|10031|EXPERIMENTAL PROCEDURES|0:0|Wild-type SP-A and all mutants bound to the affinity matrix, confirming that they were folded correctly.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20118239_170|20118239|25777|RESULTS|0:0|As expected, wild-type SP-A, which does not bind to the MASP at all, and SPA-KL, which binds only weakly, did not activate the MASP (Fig. 6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20118239_205|20118239|29998|DISCUSSION|0:0|However, in an alternative but equally valid possibility, binding of the zymogen MASP to MBL (or ficolin) induces strain into circulating complexes, which releases upon pathogen binding to trigger activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20118239_53|20118239|6889|Introduction|0:0|As yet, the only established difference between these proteins and their structural analogues is their ability to bind to MASPs or C1rs tetramers.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20118239_118|20118239|16382|RESULTS|0:0|B, binding of MASP-2A to immobilized MBLs by surface plasmon resonance.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20118239_200|20118239|28989|DISCUSSION|0:0|Thus, much of the binding specificity is probably mediated through the architectures of the subcomponents and the multivalent nature of the interactions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20118239_89|20118239|11544|EXPERIMENTAL PROCEDURES|0:0|MBL was immobilized on the chip surface rather than used as a soluble ligand because it bound to the chip, thereby masking analysis of the protein-protein interactions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20118239_101|20118239|13988|RESULTS|0:0|Consequently, during complex formation, the binding sites on the MBL stalks must either face inward or reorient so that the correct collagen-CUB domain interactions are formed.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_159|20118239|24607|RESULTS|0:0|Binding of MASP-2A to immobilized SP-As by surface plasmon resonance.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_193|20118239|27501|DISCUSSION|0:0|The presence of any additional binding sites for MASP on MBL can be completely ruled out from the data presented here.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_197|20118239|28989|DISCUSSION|0:0|Thus, the less stringent binding requirements of MASP-2 are relatively unusual.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20118239_207|20118239|29998|DISCUSSION|0:0|In the work described here, MASP binding leads to constitutive activation by SP-A, even in the absence of a target.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20118239_3|20118239|19544|#section_info|0:0|MASP activation was measured by quantifying cleavage of the MASP polypeptide.|#fig_caption|GO:0008233|peptidase activity|#go_definition|IDA|GOA|Masp2(64459)|#gene_synonym
0.66	20118239_92|20118239|12916|EXPERIMENTAL PROCEDURES|0:0|Activation was measured by following MASP autolysis using a modified version of the protocol described previously (20).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20118239_96|20118239|12916|EXPERIMENTAL PROCEDURES|0:0|Proteins were separated by SDS-PAGE under reducing conditions, and the amount of MASP cleaved was quantified by densitometry.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
